Dow Up 0.76% Nasdaq Up 0.69%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
21.17 Up 0.08(0.38%) Oct 24, 4:00PM EDT
Prev Close:21.09
Open:20.70
Bid:N/A
Ask:34.64 x 1000
1y Target Est:40.67
Beta:1.637
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:20.26 - 21.23
52wk Range:12.07 - 42.34
Volume:121,062
Avg Vol (3m):182,711
Market Cap:630.02M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OMED

Comparison

Symbol% ChgMkt Cap
OMEDUp 0.38%630.02M
STMLUp 8.34%183.32M
VSTMUp 7.03%247.82M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.50
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback